Dementia and Alzheimer’s Disease

(Limited Text - Ministerial Extracts only)

Read Full debate
Tuesday 12th April 2016

(8 years, 8 months ago)

Westminster Hall
Read Hansard Text

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Graham Stringer Portrait Graham Stringer (in the Chair)
- Hansard - - - Excerpts

We have gone slightly over time because of the unusual circumstances, so could the Front-Bench spokespeople bear that in mind? You have marginally over seven minutes, and that will leave just over a minute for Jim Shannon.

--- Later in debate ---
Jane Ellison Portrait The Parliamentary Under-Secretary of State for Health (Jane Ellison)
- Hansard - - - Excerpts

I will do my best, Mr Stringer. It is a pleasure to serve under your chairmanship. In the time available, and leaving a couple of minutes at the end, I will not be able to cover all the points raised in this excellent debate. I have never seen the Chamber this full at this time on a Tuesday morning, which is testimony to the importance of this subject.

I start by thanking the hon. Member for Strangford (Jim Shannon), who is a steadfast advocate for this vital cause. There is a great turnout on both sides of the Chamber, and it is clear—explicitly so in some speeches—that dementia and Alzheimer’s are topics that touch many of us in the Chamber today. As others have said, dementia and Alzheimer’s affect 850,000 people in the UK and impact widely on carers, families and wider society. I put on record at the outset my thanks to the wonderful national charities in this field. We value our close working relationship with them, and we value the way that they push us to be the best we can. From what has been said in this debate, it is clear that they have formed important local relationships.

Many hon. Members have made the point that dementia is a global problem that requires international collaboration to find global solutions, and the EU is helping to keep dementia on the international agenda, with the recent Italian and Luxembourg presidencies and the current presidency of the Netherlands prioritising dementia. It is an important issue and a shared agenda. Members on both sides of the House have been generous in supporting the Prime Minister’s 2020 challenge implementation plan, and I echo the support expressed by my hon. Friend the Member for Charnwood (Edward Argar) for the previous work, because we are building on important work done by the previous Labour Government. This is not a partisan issue; it is a challenge to us all. That is true internationally, too. The UK’s international leadership has been strong, and I hope that the UK’s presence will put dementia at the EU’s heart, building on the work that has already been done.

On working with Northern Ireland, as the hon. Member for Strangford knows, healthcare is a devolved matter, with each Administration responsible for its country’s healthcare, but there are many key collaborations and joint initiatives across the UK, notably in research. For example, the Medical Research Council funds dementia research across the UK, including in Northern Ireland, and people in all parts of the UK can sign up to “Join dementia research.” The subject of research has rightly has been much touched on. In particular, the challenges were ably outlined by my hon. Friend the Member for North West Hampshire (Kit Malthouse), who explained why there are particular challenges in this area.

I will reiterate some of the commitments that the Government have made. There will be: up to £150 million for the UK-wide Dementia Research Institute; £300 million to invest in dementia research by 2020; an increase in the total funding for dementia research from the National Institute for Health Research, research councils and charity partners; and more opportunities to participate in research. By 2018, 12% of people newly diagnosed each year will be registered on “Join dementia research,” with 10% participating, but there is more to do. Understanding the causes of dementia will help us to drive the development of treatments and industry innovation. Through things such as the dementia discovery fund, we want to ensure that we have innovative international approaches to making the most of the opportunities that come in the search for a treatment or a disease-modifying therapy, on which we have set ambitious targets.

I also stress, because it has come up again in this debate, the importance of research that also helps us to know best how to support, how to care for and how to improve the lives of people. We are funding things that will have immediate benefits within the next 12 months, as well as things that we hope will bring about a cure or a disease-modifying therapy. One example is that we have commissioned a £20 million research initiative on living well with dementia, funded by the NIHR and the Economic and Social Research Council, which focuses on issues that really matter to people in terms of the practical, day-to-day challenges. Again, there will be opportunities to talk about those in the House.

We have made big progress. Record numbers of people are joining dementia research. We have ambitious targets in that regard, and I hope that hon. Members on both sides of the House can help us to meet them. Diagnosis is vital, as has been mentioned in the debate. Again, huge improvements have been made in the diagnosis rate, from 42% in 2010-11 to 67.4% at the end of February 2016, an increase of around 25 percentage points, but there is more to do, particularly to drive out variation. There is still considerable variation, but ongoing and regular effort is being put into that. I pay tribute to the considerable leadership being given by the NHS’s national clinical director, Alistair Burns.

Meaningful care has rightly been highlighted by Members on both sides as one of the biggest challenges. I am supported by an excellent team of officials in this area, and they are well aware that this is a challenging area. In particular, post-diagnostic support is challenging for the person who is diagnosed, but it is especially challenging for their carers and family. The hon. Member for Bradford South (Judith Cummins) was right to pay tribute to some of her local initiatives and to highlight how big this area is. The joint declaration on post-diagnostic dementia care and support was signed by leaders across the health, social care, local government and voluntary sectors, and it is the first time that we have had an unequivocal joint commitment to improving care and support for people with dementia and their carers following diagnosis. We want to see joined-up plans for health and care support in every area, with personalised care plans for every person with dementia. With NHS England and other partners, we have developed ways to drive that and to measure it within our implementation plan.

Members have rightly said that carers play a pivotal role. I am all too aware of the strain that a dementia diagnosis puts on other family members, which has been rightly highlighted in this debate. We recognise and pay tribute to the pivotal role that carers play. I have touched on progress in research, but I emphasise that we want to see people with dementia, their families and carers live well and have meaningful support.

Time does not allow me to talk in any detail about the carers strategy, but we have launched a call for evidence to inform the cross-Government national carers strategy on what more can be done, and there is clearly much to do in the field of dementia. I encourage all Members to contribute to that, and to encourage their local groups to do so. Carer’s allowance has been touched on. We are rightly being challenged on the money being spent on care, but we are spending more than £2 billion a year on carers’ benefits in Great Britain, supporting more than 750,000 carers. The rate of carer’s allowance has increased since 2010, but I am afraid that time does not permit me to go into detail. I am sure there will be occasions to do so in other debates.

We are further supporting the implementation of improved rights for carers—including carers for those with dementia—enshrined in the Care Act 2014. That is backed by £104 million of funding in 2015-16. The better care fund brings the great promise of more important work on integration, and there are some exciting examples of local initiatives, particularly coming out of Greater Manchester. Again, there will be other opportunities to talk about how the better care fund and those integrated vanguard models can lead the way to more improved care and support for people with dementia.

The role that charities and communities play in enabling people with dementia and their carers to live well through initiatives such as sport, music and dementia cafés has rightly been mentioned. There are some wonderful initiatives, including the Sporting Memories Network, and I pay tribute to all the local initiatives mentioned by hon. Members. I was recently privileged to visit an initiative led by the Manchester Camerata and its music therapist—wonderful work is being done there. There are some 1.5 million dementia friends in England and Northern Ireland doing wonderful work, and a public awareness campaign is under way in Northern Ireland.

There is little I can say in the time available on risk reduction other than that it is vital. Dementia is not an inevitable part of ageing, and up to 20% of those diagnosed with dementia have vascular dementia, the effects of which can be minimised or prevented altogether by a healthy lifestyle. Members are right to draw attention to work on factors such as alcohol, exercise and weight—I hope there will be a chance to say more about that in a future debate. I ask Members to encourage their constituents to take up their free NHS health check. We are piloting initiatives on early-onset dementia awareness.

Let me end by congratulating all hon. Members on their contributions. I refer them to our implementation plan, which was launched last month and has much detail about how we are responding to the Prime Minister’s 2020 challenge. As I close and leave a few seconds for the hon. Member for Strangford to respond, I reiterate that the Government’s commitment to this subject is absolutely undimmed, and it is clear from the contributions this morning that Parliament’s commitment to this important cause also burns brightly.